We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Commentary |

Enhancing the Safety of Hospitalized Patients: Who Is Minding the Antimicrobials?  Comment on “Overtreatment of Enterococcal Bacteriuria”

Scott A. Flanders, MD; Sanjay Saint, MD, MPH
Arch Intern Med. 2012;172(1):38-40. doi:10.1001/archinternmed.2011.595.
Text Size: A A A
Published online


Guidelines have long recommended against using antimicrobials in hospitalized patients who have bacteriuria but no symptoms of a urinary tract infection (UTI). Asymptomatic bacteriuria is commonly found in hospitalized patients, often when urine cultures are appropriately ordered in patients with complex problems for which UTI may provide one of many possible explanations. Unfortunately, when asymptomatic bacteriuria is identified, antimicrobials often follow.1 In this issue of the Archives, Lin and colleagues2 evaluate antimicrobial use in patients with enterococcal bacteriuria. The authors retrospectively reviewed medical records at 2 academic medical centers and identified 339 urine cultures that yielded enterococci. Applying the diagnostic criteria of the Infectious Diseases Society of America, the authors found that 183 of these patients had asymptomatic bacteriuria. Of all patients with enterococcal asymptomatic bacteriuria, 33% inappropriately received antimicrobials. Somewhat disturbingly, nearly 15% of patients who were legitimately diagnosed as having UTI did not receive antimicrobials. To make matters even worse, for patients with both UTI and asymptomatic bacteriuria, the most commonly used antimicrobials were quinolones, which are broad-spectrum agents with little activity against enterococci.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections